Gene Therapy
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Genetics
Q1
└
Molecular Biology
Q1
└
Molecular Medicine
Q1
Publisher
SJR 2025
1.502
Q1
SJR Score
H-Index
181
Citations / Doc (2yr)
4.57
Total Docs. (latest)
81
Total Citations (3yr)
1,090
Publication type
Journals
ISSN
09697128, 14765462
Coverage
1994-2026
Journal Rank
#2,440
Subject Categories
Genetics
Q1
Molecular Biology
Q1
Molecular Medicine
Q1
Subject Areas
Aims & Scope
Gene Therapy covers both the research and clinical applications of novel therapeutic techniques based on a genetic component.
Over the last few decades, significant advances in technologies ranging from identifying novel genetic targets that cause disease through to clinical studies, which show therapeutic benefit, have elevated this multidisciplinary field to the forefront of modern medicine.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 81 |
| Total Docs. (3 years) | 235 |
| Total Refs. | 4,472 |
| Total Citations (3 years) | 1,090 |
| Citable Docs. (3 years) | 222 |
| Citations / Doc. (2 years) | 4.57 |
| Ref. / Doc. | 55.21 |
| % Female | 46.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Gene Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Gene Therapy has an SJR of 1.502 and is ranked Q1.
What is the SJR and quartile of Gene Therapy?
Gene Therapy has an SJR (SCImago Journal Rank) of 1.502 and its best quartile is Q1.
What is the H-index of Gene Therapy?
The H-index of Gene Therapy is 181, meaning 181 of its articles have each been cited at least 181 times.
Is Gene Therapy indexed in Scopus?
Yes. Gene Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.